✦ LIBER ✦

Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: Chasing windmills?

✍ Scribed by Gary L. Davis

Book ID: 111700959
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 62 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20889

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine after hepatitis B immune glob

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

✍ S. Forrest Dodson; Michael E. de Vera; C. Andrew Bonham; David A. Geller; Jorge 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Substitution of tenofovir/emtricitabine

Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation

✍ R. Todd Stravitz; Mitchell L. Shiffman; Melissa Kimmel; Puneet Puri; Velimir A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Treatment of patients with decompensated

Treatment of patients with decompensated post-hepatitis C cirrhosis before liver transplantation: strategy to prevent hepatitis C virus (HCV) recurrence?

✍ Jean-Pierre Zarski; Marie-Noëlle Hilleret 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Intramuscular hepatitis B immune globuli

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

An efficacy and cost-effectiveness analy

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

✍ Steven-Huy B. Han; Joshua Ofman; Curtis Holt; Kevin King; Gregg Kunder; Pauline 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Combination hepatitis B immune globulin

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients

✍ Z Ben-Ari; E Mor; N Bar-Nathan; E Shaharabani; Z Shapira; R Tur-Kaspa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB